Abstract
An antimicrobial screening of six different extracts of Plectranthus ornatus, revealed anti-Gram positive bacteria activity for the acetone and methanol-water extracts. 11R*-Acetoxyhalima-5,13E-dien-15-oic acid (1), isolated from the acetone extract of P. ornatus, exhibited growth inhibitory activity against five Staphylococcus and five Enterococcus strains. [MIC values 15.62 μg/mL (43.15 μM) – 62.50 μg/mL (172.65 μM)]. Diterpenes with a halimane skeleton are rarely isolated and their pharmacologic properties remain unknown. To study the potential of 1 as antibacterial prototype some derivatives (2-10) were obtained from 1 and the majority were tested against the same ten Gram positive bacteria. The more active was the (11R*,13E)-halima-5,13-diene-11,15-diol (4) with MIC values of 15.62 μg/mL (51.05 μM) to 31.25 μg/mL (102.12 μM). The preparation and spectroscopic data of 2 – 10 are also reported.
Keywords: 11R*-Acetoxyhalima-5, 13E-dien-15-oic acid, antimicrobial activity, diterpenes, halimane derivatives, labiatae, Plectranthus ornatus extracts, anti-Gram positive bacteria activity, ethnomedicinal plant, non-volatile components, clerodane
The Natural Products Journal
Title: Antimicrobial Properties of Plectranthus ornatus Extracts, 11-acetoxyhalima-5, 13-dien-15-oic Acid Metabolite and its Derivatives
Volume: 1 Issue: 1
Author(s): Patricia Rijo, Benjamin Rodriguez, Aida Duarte and M. Fatima Simoes
Affiliation:
Keywords: 11R*-Acetoxyhalima-5, 13E-dien-15-oic acid, antimicrobial activity, diterpenes, halimane derivatives, labiatae, Plectranthus ornatus extracts, anti-Gram positive bacteria activity, ethnomedicinal plant, non-volatile components, clerodane
Abstract: An antimicrobial screening of six different extracts of Plectranthus ornatus, revealed anti-Gram positive bacteria activity for the acetone and methanol-water extracts. 11R*-Acetoxyhalima-5,13E-dien-15-oic acid (1), isolated from the acetone extract of P. ornatus, exhibited growth inhibitory activity against five Staphylococcus and five Enterococcus strains. [MIC values 15.62 μg/mL (43.15 μM) – 62.50 μg/mL (172.65 μM)]. Diterpenes with a halimane skeleton are rarely isolated and their pharmacologic properties remain unknown. To study the potential of 1 as antibacterial prototype some derivatives (2-10) were obtained from 1 and the majority were tested against the same ten Gram positive bacteria. The more active was the (11R*,13E)-halima-5,13-diene-11,15-diol (4) with MIC values of 15.62 μg/mL (51.05 μM) to 31.25 μg/mL (102.12 μM). The preparation and spectroscopic data of 2 – 10 are also reported.
Export Options
About this article
Cite this article as:
Rijo Patricia, Rodriguez Benjamin, Duarte Aida and Fatima Simoes M., Antimicrobial Properties of Plectranthus ornatus Extracts, 11-acetoxyhalima-5, 13-dien-15-oic Acid Metabolite and its Derivatives, The Natural Products Journal 2011; 1 (1) . https://dx.doi.org/10.2174/2210315511101010057
DOI https://dx.doi.org/10.2174/2210315511101010057 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers